Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Saved in:
| Title: | Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. |
|---|---|
| Authors: | Wang W; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China., Zhang W; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. vv1223@vip.sina.com., Su LP; Department of Hematology, Shanxi Provincial Cancer Hospital, 3 Worker's New Village, Xinghualing District, Taiyuan, Shanxi, China. Sulp2005@sohu.com., Liu LH; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Gao YH; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Wang QS; Department of Hematology, Chinese PLA General Hospital, Beijing, China., Su H; Department of Lymphoma, The 307 Hospital of PLA, Beijing, China., Song YQ; Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China., Zhang HL; Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Shen J; Department of Hematology, Beijing Friendship Hospital, Beijing, China., Jing HM; Department of Hematology, Peking University Third Hospital, Beijing, China., Wang SY; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin, China., Cen XN; Department of Hematology, Peking University First Hospital, Beijing, China., Liu H; Department of Hematology, Beijing Hospital, Beijing, China., Liu AC; Department of Lymphoma, Harbin Medical University Cancer Hospital, Harbin, China., Li ZJ; Lymphoma Diagnosis and Treatment Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China., Luo JM; Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China., He JX; Department of Hematology, Shanxi Provincial People's Hospital, Taiyuan, China., Wang JW; Department of Hematology, Beijing Tongren Hospital, Beijing, China., O'Connor OA; Columbia University Medical Center, New York, NY, USA., Zhou DB; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. |
| Source: | Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3061-3069. Date of Electronic Publication: 2024 May 28. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase II; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38805037 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. vv1223@vip.sina.com.<br /><searchLink fieldCode="AU" term="%22Su+LP%22">Su LP</searchLink>; Department of Hematology, Shanxi Provincial Cancer Hospital, 3 Worker's New Village, Xinghualing District, Taiyuan, Shanxi, China. Sulp2005@sohu.com.<br /><searchLink fieldCode="AU" term="%22Liu+LH%22">Liu LH</searchLink>; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22Gao+YH%22">Gao YH</searchLink>; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22Wang+QS%22">Wang QS</searchLink>; Department of Hematology, Chinese PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Su+H%22">Su H</searchLink>; Department of Lymphoma, The 307 Hospital of PLA, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Song+YQ%22">Song YQ</searchLink>; Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+HL%22">Zhang HL</searchLink>; Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Shen+J%22">Shen J</searchLink>; Department of Hematology, Beijing Friendship Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jing+HM%22">Jing HM</searchLink>; Department of Hematology, Peking University Third Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+SY%22">Wang SY</searchLink>; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin, China.<br /><searchLink fieldCode="AU" term="%22Cen+XN%22">Cen XN</searchLink>; Department of Hematology, Peking University First Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Department of Hematology, Beijing Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+AC%22">Liu AC</searchLink>; Department of Lymphoma, Harbin Medical University Cancer Hospital, Harbin, China.<br /><searchLink fieldCode="AU" term="%22Li+ZJ%22">Li ZJ</searchLink>; Lymphoma Diagnosis and Treatment Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Luo+JM%22">Luo JM</searchLink>; Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22He+JX%22">He JX</searchLink>; Department of Hematology, Shanxi Provincial People's Hospital, Taiyuan, China.<br /><searchLink fieldCode="AU" term="%22Wang+JW%22">Wang JW</searchLink>; Department of Hematology, Beijing Tongren Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22O'Connor+OA%22">O'Connor OA</searchLink>; Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+DB%22">Zhou DB</searchLink>; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3061-3069. <i>Date of Electronic Publication: </i>2024 May 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase II; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38805037 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-024-05708-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3061 Titles: – TitleFull: Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang W – PersonEntity: Name: NameFull: Zhang W – PersonEntity: Name: NameFull: Su LP – PersonEntity: Name: NameFull: Liu LH – PersonEntity: Name: NameFull: Gao YH – PersonEntity: Name: NameFull: Wang QS – PersonEntity: Name: NameFull: Su H – PersonEntity: Name: NameFull: Song YQ – PersonEntity: Name: NameFull: Zhang HL – PersonEntity: Name: NameFull: Shen J – PersonEntity: Name: NameFull: Jing HM – PersonEntity: Name: NameFull: Wang SY – PersonEntity: Name: NameFull: Cen XN – PersonEntity: Name: NameFull: Liu H – PersonEntity: Name: NameFull: Liu AC – PersonEntity: Name: NameFull: Li ZJ – PersonEntity: Name: NameFull: Luo JM – PersonEntity: Name: NameFull: He JX – PersonEntity: Name: NameFull: Wang JW – PersonEntity: Name: NameFull: O'Connor OA – PersonEntity: Name: NameFull: Zhou DB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 103 – Type: issue Value: 8 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |
